• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMedicines

Medicines

0
Close-up of a patient administering a dose of Zepbound (tirzepatide)
HealthZepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
By Lindsey LeakeDecember 4, 2024
Modern-day hippie moms have found solace in one Trump appointee: RFK Jr.
LifestyleModern-day hippie moms have found solace in one Trump appointee: RFK Jr.
By Sydney LakeDecember 4, 2024
Julie Wainwright
CommentaryCount me among the boomers not retiring—I’m in my 60s and leading another startup
By Julie WainwrightOctober 22, 2024
MeAgainMeds.com, a free tool developed by researchers at the George Mason University College of Public Health in Fairfax, Va., uses AI to pair people with depression with the best available antidepressant medication for them.
MindAntidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By Lindsey LeakeAugust 14, 2024
Good DeepMind CEO Demis Hassabis and John Jumper, the scientist who heads the company's protein structure team, accepting a Breakthrough Pirze for their work on AlphaFold 2.
TechGoogle DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By Jeremy KahnMay 8, 2024
Big Pharma's favorite lab monkey, the long-tailed macaque.
MagazineBig Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline
By Erika FryJanuary 27, 2024
New lawsuits target abortion pill restrictions in North Carolina and West Virginia
PoliticsNew lawsuits target abortion pill restrictions in North Carolina and West Virginia
By Matthew Perrone and The Associated PressJanuary 26, 2023
New York City will home-deliver free antiviral pills to COVID-19 patients
HealthNew York City will home-deliver free antiviral pills to COVID-19 patients
By Ian Fisher and BloombergJanuary 31, 2022
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
HealthGermany will make COVID vaccinations mandatory if Angela Merkel gets her way
By Christiaan HetznerDecember 2, 2021
In patient with long-term COVID-19, coronavirus mutated to resist antiviral Remdesivir
HealthIn patient with long-term COVID-19, coronavirus mutated to resist antiviral Remdesivir
By Jason Gale and BloombergNovember 11, 2021
Merck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
HealthMerck’s new COVID-19 antiviral pill gets its first national approval—from the U.K.
By Frank Connelly and BloombergNovember 4, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
HealthMerck says poorer countries can produce its new COVID pill without paying royalties
By David MeyerOctober 27, 2021
Will COVID-19 change how Big Pharma does clinical trials?
MagazineWill COVID-19 change how Big Pharma does clinical trials?
By Erika FryMay 15, 2020
Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?
MagazineMedicine by machine: Is A.I. the cure for the world’s ailing drug industry?
By Jennifer AlseverJanuary 20, 2020
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
FinanceNovartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By James Paton and BloombergNovember 25, 2019
0
Most Popular
North America
The World Cup is supposed to be an economic windfall. But 'you're seeing a number of headwinds' nowplaceholder alt text
By Fortune EditorsApril 4, 2026
Personal Finance
College grads in ‘AI-proof’ careers like psychology and education are seeing negative returns on their degreesplaceholder alt text
By Fortune EditorsApril 4, 2026
Success
Major 4-day workweek study suggests that when we work 5 days we spend one doing basically nothingplaceholder alt text
By Fortune EditorsApril 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.